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Abstract: A 63-year-old woman, who presented with severe jaundice and elevated serum 
  conjugated bilirubin level, denied alcohol and drug use and showed no evidence of viral hepatitis. 
Based on clinical and laboratory features, she was diagnosed with autoimmune hepatitis with 
primary biliary cirrhosis. Hematological and immunochemical assays, radiographic imaging, 
clinical examination, and liver biopsy were conducted. Laboratory results were the following: 
negative for fluorescence antinuclear antibody, negative for antismooth muscle antibodies but 
positive for antinuclear antibody (enzyme-linked immunosorbent assay) and antimitochondrial 
M2 antibody, high titers of serum globulin, and positive for cytomegalovirus IgM. Liver biopsy 
showed submassive lobular necrosis, inflammation with broad areas of parenchymal collapse, 
and chronic nonsuppurative destructive cholangitis. The patient responded well to corticosteroid 
therapy. This case might illustrate an association between cytomegalovirus infection and the 
occurrence of autoimmune hepatitis.
Keywords: autoimmune hepatitis, fluorescence antinuclear antibody, enzyme linked immuno 
sorbent assay, primary biliary cirrhosis, cytomegalovirus infection
Introduction
Autoimmune hepatitis (AIH) is characterized by chronic necroinflammation, 
  manifesting as severe lobular necrosis and inflammation with broad areas of parenchy-
mal collapse with no known cause. Immune reactions against host antigens are found 
to be the major pathologic mechanism. In fact, AIH might be associated with a number 
of other autoimmune diseases,1 but the exact mechanisms of onset remain unknown. 
In AIH, the immune system produces one or more types of autoantibodies. The most 
common are antinuclear antibodies (ANA), smooth muscle antibodies (SMA), and 
antibodies to liver and kidney microsomes (anti-LKM).1 Evidence suggests that AIH 
is induced by antibody-dependent cell-mediated cytotoxicity, which involves both 
antibody-mediated and cellular immunity against specific liver antigens on hepatocyte 
membranes.2 Several studies have documented the involvement of genetic factors 
including human leukocyte antigen (HLA) types DR3 and DR4.3 Some reports have 
described AIH cases in which a virus such as hepatitis A,4 hepatitis B,5 or Epstein–
Barr6 was the causative agent.
Sera from patients with multiple autoimmune diseases have been found to have 
elevated cytomegalovirus (CMV) IgM titers, perhaps implying an as yet unidentified 
association between CMV and autoimmune diseases.7
We present a case of fluorescence ANA-negative AIH-associated primary biliary 
cirrhosis (PBC) that appears to have been triggered by reactivated CMV infection.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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Table 1 Laboratory data
erythrocyte sedimentation rate 2 /l hr
Blood count
White blood cells 3.70 3.30–9.00 mL
red blood cells 3.84 3.38–500 × 104/mL
Hemoglobin 11.4 11.5–15.0 g/dL
Hematocrit 34.2 34.8%–45.0%
Platelets 10.1 14–34 × l04/μL
Blood coagulation
Prothrombin time and 
international normalized ratio 
1.93 0.85–1.15
Hepaplastin test 26 70%–130%
Antithrombin III 36 81–12
Urinalysis
Gravity 1.021 1.006–1.0
pH 6 4.5–8.0
Glucose (-) (-) mg/dL
Protein (-) (-) mg/dL
Blood (-) (-)
Ketone (-) (-)
Bilirubin (-) (-)
Urobilinogen (-) (-)
Blood chemistry
Total bilirubin 6.6 0.2–1.2 mg/dL
Direct bilirubin 4.4 0.0–0.2 mg/dL
Aspartate aminotransferase 344 10–40 IU/L
Alanine aminotransferase 238 5–45 IU/L
γ-glutamyl transpeptidase 129 30 IU/dL
Alkaline phosphatase 572 100–325 IU/l
Cholinesterase 112 200–452 IU/I
Total protein 7.3 6.7–8.3 g/dL
Albumin 3.3 3.8–5.3 g/dL
Total cholesterol 133 120–219 mg/dL
Blood urea nitrogen 6.3 18.0–20.0
Creatinine 0.62 0.47–0.71 mg/dL
Fasting blood sugar 143 70–109 mg/dL
Immunological and 
serological data
Hepatitis B surface antigen (-)
Hepatitis C surface antigen (-)
Hepatitis A antibody (-) ,0.71
IgM Hbc antibody (-) ,1.0
Hepatitis C virus rNA ,1.2 ,1.2 loglU/mL
CMV-IgM 2.127 (+) ,0.8
CMV-IgG 10 (+) ,0.8
eBV-VCA IgM ,10 ,×l0
eBV-VCA IgG 1280 ,×l0
eBV-DNA PCr (-)
IgG 2496 870–1700 mg/dL
IgM 272 46–260 mg/dL
Fluorescent antinuclear antibody 
test 
,×40 ,×40
Antinuclear antibody (eLIsA) 44.1 (+) ,20 index
Anti-smooth muscle antibody ,×20 (-) ,×20
Liver kidney microsomal type 1 
antibody
,1.7 (-) ,5.0
Anti-mitochondria M2 antibody 18.4 (+) ,7.0
(Continued)
Case report
In 2010, a 63-year-old Japanese woman was admitted to a 
local hospital, after which she was transferred to our hospital 
for investigation of liver dysfunction. One month prior, she 
had experienced fever. She had no history of medicine or drug 
use. The findings of physical examinations of admission to 
our hospital were the following: body temperature, 36.8°C; 
pulse rate, 69 beats/minute and regular; blood pressure, 
122/77 mmHg; respiratory rate, 16/minute; no sign of anemia 
at the conjunctiva palpebra, but an icteric finding was made at 
the conjunctiva bulbi. She had no skin rash or erythema. No 
flapping tremor or palmar erythema was observed. Superficial 
lymph nodes were not palpable. The lungs were normal on 
auscultation. A chest radiograph and an electrocardiogram 
were normal. The results of urinalysis were normal, with the 
exception of a positive result for urobilinogen. The results of 
biochemical analysis of the blood were the following: total 
bilirubin, 6.6 mg/dL (normal range: 0.2–1.2); direct bilirubin, 
4.4 mg/dL (normal range: 0.0–0.2); aspartate aminotransferase, 
344 IU/L (normal range: 10–40); alanine aminotransferase, 238 
IU/L (normal range: 5–45); alkaline phosphatase, 572 IU/L 
(normal range: 100–325); γ-guanosine triphosphate, 129 IU/L 
(normal value: ,30); IgG, 2,498 mg/dL (normal range: 
870–1,700); and IgM, 279 mg/dL (normal range: 46–260). 
CMVIgM antibody was high; IgG antibody was above the 
normal ranges at admission (Table 1).
Tests for hepatitis A IgM antibody, hepatitis B surface 
antigen, and anti-hepatitis C virus antibody were   negative. 
ANA was negative by fluorescence assay (,×40), 
but it was positive as measured using enzyme-linked 
immunosorbent assay (ELISA) (44.1 index; normal 
range ,20), anti-mitochondria M2 antibody level was 
18.4 (normal value: ,7.0), anti-LKM antibody was 
negative, anti-SMA was ,×20, and anti-dsDNA anti-
body (,7.0 IU/mL; normal value: ,20 IU/mL) was 
negative. The test result for HLA-DR4 was positive. 
The level of   anti-ribonucleoproteins antibody was 20.3 
(normal value: ,17) (Table 1).
Abdominal ultrasonography and computed tomography 
were conducted to determine the cause of hepatic dysfunction. 
Ascites, but no abdominal mass, were detected (Figure 1). A 
needle liver biopsy was performed on the third hospital day. 
Histological examination showed severe lobular necrosis, 
inflammation with broad areas of parenchymal collapse, 
and both nondestructive and destructive cholangitis sur-
rounded by many lymphocytes and plasma cells (Figure 2). 
Regarding results of electron microscopy, migrating   
lymphocytes were found more frequently in a medium-sized International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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Figure  1  Abdominal  computed  topography  finding.  Arterial  phase  computed 
tomography shows no abdominal mass, but ascites.
Table 1 (Continued)
Thyroid stimulating hormone 1.254 0.436–3.8 μlU/mL
Free thyroxine 1.14 1.0–1.7 ng/dL
Thyroglobulin 0.7 (+) ,0.3 U/mL
rheumatoid factor 25 (+) ,20
rheumatoid arthritis 
hemagglutinin ,×40
20 (-) ,40
Cyclic citrullinated peptide 8 (-) ,4.5 U/mL
Lupus anticoagulant: dilute 
russell viper venom time
1.1 (-) ,1.3
DNA 5 (-) ,6
Classicla antineutrophil 
cytoplasmic antibody
,3.5 (-) ,3.5 U/mL
Protoplasmic-straining 
antineutrophil cytoplasmic 
antibodies
,1.3 (-) ,9.0 U/mL
Total complement activity 37.1 (-) 29.0–48.0 U/mL
Anti-Jo-1 antibody ,1.0 (-) ,1.0
Anti-ribonucleoprotein antibody 20.3 (+) ,17.0
Anti-ss-A antibody ,5.0 (-) ,15
Anti-ss-B antibody ,5.0 (-) ,15.0
Anti-centromere antibody 6.5 (-) ,10.0
Anti-scl-70 antibody ,5.0 (-) ,16
HLA-Dr haplotypes Dr-4
Abbreviations: CMV, cytomegalovirus; DNA, deoxyribonucleic acid; eBV, epstein-
Barr virus; Ig Immunoglobulin; PCr, polymerase chain reaction; rNA, ribonucleic 
acid; VCA, virus capsid antigen.
interlobular bile duct surrounded by many inflammatory 
cells. One lymphocyte had just migrated through the bile 
duct epithelial cells. Complete absence or partial loss of 
microvilli and microvillous bleb formation was visible in 
the same bile duct epithelial cell (Figure 3).
The clinical and pathological findings were highly sug-
gestive of AIH, the score of which was calculated accord-
ing to the system proposed by the revised International 
AIH Group.8 The negative ANA result assessed by 
fluorescent ANA was used in the calculation. The AIH 
score was 9, corresponding to nondiagnosis of AIH. The 
clinical/  pathological findings of anti-mitochondria M2 anti-
body and chronic nonsuppurative destructive   cholangitis 
indicated PBC. The final diagnosis might be overlapping 
syndrome of AIH and PBC preceding CMV infection. 
Her severe jaundice was improved, and her bilirubin and 
transaminase levels began to decline after administration 
of prednisolone for 3 days. They were normalized after 
1 month (Figure 4).
Discussion
The role of viruses in AIH has been proposed   repeatedly, 
but convincing evidence has linked two viruses – hepatitis 
A and Epstein–Barr virus – to type 1 of the disease, only in 
rare cases where a genetic predisposition exists and the viral 
infection occurs at the right time. In spite of an impressive 
amount of information conclusively showing molecular 
mimicry between cytochrome P4502D6 sequences (the 
target autoantigen of autoantibodies characteristic of AIH 
type 2) and viral (hepatitis C virus, herpes simplex virus 1, 
CMV , human T lymphotropic viruses 1 and 2) or bacterial 
(Salmonella typhimurium) antigens, no infectious agent has 
been clearly implicated for causing type 2 of the disease.9 
At admission and at 2, 4, and 8 weeks after admission, the 
respective CMV IgM indices (normal value: ,0.8) were 2.17, 
0.93, 1.08, and 1.407; and IgG indices (normal value: ,2.0) 
were 10, 34, 89.4, .128, and .128. Consequently, serial 
CMV Ig measurements demonstrated a slight increase of IgM 
at admission which declined gradually over time, whereas 
IgG increased with time to very high levels. These findings 
suggested CMV infection, consistent with a previous report 
that some patients with secondary CMV infection had long-
lasting IgM antibodies, and that all had IgG antibodies to 
CMV .10
The present case is a rare case of negative fluorescence-
ANA and low-titer ELISA-ANA AIH type 1 with coincident 
CMV infection. Furthermore, LKM antibodies were also 
negative. Although the clinical features strongly suggest 
AIH, calculation of AIH score using the result did not 
recommend a diagnosis of AIH from negative fluorescence-
ANA. Immunofluorescence assay is the ANA detection 
method used in the calculation of AIH score.8 Although 
immunofluorescence is a sensitive test, it is laborious when 
testing large quantities of patient samples and is subject to 
errors of human interpretation and variation in fluorescence 
microscopes.11 The enzyme immunoassay test system is an 
excellent alternative to the immunofluorescence assay sys-
tem for screening patient serum for the presence of clinically International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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significant ANAs. The enzyme immunoassay efficiently 
screens large quantities of patient samples and reduces risks 
of human error.12 Both methods have different issues with 
respect to precision.
Our patient was positive for AMA, and liver biopsy 
showed a mixed portal inflammatory infiltrate with 
destructive and nondestructive cholangitis (Figure 3C). 
The reported frequency of AMA in patients with   definitive 
AIH was 18 in 206 (7.5%) patients as assessed by 
  immunoblotting.13 Therefore, AMA positivity is not a 
typical AIH finding. In the present case, the findings 
of AMA positivity and destructive biliary injury resem-
bling chronic nonsuppurative destructive cholangitis 
in the biopsy strongly suggest a diagnosis of PBC.14 
Although AIH and PBC might share some common 
histological features, the patterns seen on liver biopsy 
typically differ. Interface hepatitis or lobular hepatitis 
with infiltration of plasma cells is a characteristic of 
acute or chronic AIH.15 Nondestructive ductular reaction 
is detected more frequently in acute AIH than in chronic 
disease, but the destructive cholangitis lesions that are 
typical of PBC are not present.15,16 Moreover, for electron 
microscopy, the bile duct epithelial cell membrane facing 
the lymphocyte was disrupted. Lymphocyte – bile duct 
epithelial cell detachment is an important ultrastructural 
lesion associated with extensive bile duct destruction in 
PBC livers.17 Cellular immune mechanisms involving T 
cell reaction were thought to be significantly involved 
in the formation of chronic nonsuppurative destructive 
cholangitis and bile duct loss.18
5 µm 
Figure 3 electron microscopy findings.
Notes:  Migrating  lymphocytes  were  found  more  frequently  in  a  medium-sized 
interlobular bile duct surrounded by many inflammatory cells. One lymphocyte had 
just migrated through the bile duct epithelial cells. Complete absence or partial 
loss of microvilli and microvillous bleb formation was visible in the same bile duct 
epithelial cell. The arrow indicates bleb formation. The arrowhead denotes migrating 
lymphocytes through the bile duct epithelial cells.
A
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150 µm
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Figure 2 Needle biopsy specimen of the liver.
Notes: A) Low magnification of silver impregnation staining for reticulin showing broad areas of parenchymal collapse. B) High magnification of a hematoxylin and eosin 
stained section showing interfacial hepatitis (arrow). C) High magnification of a hematoxylin and eosin stained section showing non-destructive cholangitis (black arrowhead) 
and destructive cholangitis (white arrowhead) surrounded by numerous plasma lymphocytic cells.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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In our case, the presence of portal inflammation and 
mixed destructive and nondestructive cholangitis changes, 
supported by other biochemical changes, led to a final diag-
nosis of overlapping syndrome of acute exacerbation AIH 
and PBC. This case is rare because these changes coincide 
or even precede CMV infection.
In the present case, ELISA assay for ANA and liver 
biopsy led to AIH and early treatment with prednisolone, 
which produced a good clinical outcome.
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